Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptide
SSX2IP
Reactivité: Mammifères
Hôte: Synthetic
BP, IHC, WB
N° du produit ABIN940092
382,12 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 20 à 27 jours ouvrables
Aperçu rapide pour Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptide (ABIN940092)
Antigène
SSX2IP
(Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Type de proteíne
- Synthetic
-
Séquence
- KVHLEGFNDE DVISRQDHEQ ETEKLELEIQ QCKEMIKTQQ QLLQQQLATA
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX2 IP antibody,
Alternative Names: SSX2IP control peptide, SSX2IP antibody Blocking Peptide, Anti-SSX2IP Blocking Peptide, Synovial Sarcoma X Breakpoint 2 Interacting Protein Blocking Peptide, ADIP Blocking Peptide, FLJ10848 Blocking Peptide, KIAA0923 Blocking Peptide, MGC75026 Blocking Peptide, SSX2IP, SSXIP-2, SSXIP 2, SSXIP-2 Blocking Peptide, SSXIP 2 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
-
Sujet
- SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
-
Poids moléculaire
- 68 kDa
Antigène
-
Vous êtes ici:
